INDICATION: Cirrhosis; hepatitis; liver disease...
BCIQ Company Profiles
Parvus Therapeutics Inc.
University of Calgary
BCIQ Target Profiles
Major histocompatibility complex class II (MHCII)
Pyruvate dehydrogenase (PDH)
